Acrylamide exposure and incidence of breast cancer among postmenopausal women in the Danish Diet, Cancer and Health study

International Journal of Cancer

Volumn 122, Issue 9, 2008, Pages 2094-2100

  Olesen, Pelle Thonning ^a   Olsen, Anja ^b   Frandsen, Henrik ^a   Frederiksen, Kirsten ^b   Overvad, Kim ^c   Tjønneland, Anne ^b  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Acrylamide; Biomarkers; Breast cancer; Epidemiology; Glycidamide

Indexed keywords

ACRYLAMIDE; ALCOHOL; BIOLOGICAL MARKER; CARCINOGEN; ESTROGEN RECEPTOR; GLYCIDAMIDE; HEMOGLOBIN; EPOXIDE;

ADULT; ALCOHOL CONSUMPTION; AMINO TERMINAL SEQUENCE; ARTICLE; BODY MASS; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER INCIDENCE; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; CONFOUNDING VARIABLE; CONTROLLED STUDY; DENMARK; DIETARY INTAKE; DISEASE ASSOCIATION; EDUCATIONAL STATUS; ERYTHROCYTE; EXPOSURE; FEMALE; GENOTOXICITY; HEMOGLOBIN DETERMINATION; HORMONAL THERAPY; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; METABOLITE; PARITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; AGED; BLOOD; BREAST TUMOR; ENVIRONMENTAL EXPOSURE; INCIDENCE; MEDICAL RECORD; METABOLISM; MIDDLE AGED; REGISTER; RISK; RISK FACTOR;

ACRYLAMIDE; AGED; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; DENMARK; ENVIRONMENTAL EXPOSURE; EPOXY COMPOUNDS; FEMALE; HEMOGLOBINS; HUMANS; INCIDENCE; MEDICAL RECORD LINKAGE; MIDDLE AGED; ODDS RATIO; POSTMENOPAUSE; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; SMOKING;

EID: 40749148993     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23359     Document Type: Article

References (57)

1. International Agency for Research on Cancer IARC). Acrylamide, IARC monographs on the evaluation of carcinogenic risks to humans, some industrial chemicals, vol. 60. Lyon: International Agency for Research on Cancer, 1994. 389-433.
2. Hagmar L, Törnqvist M, Nordander C, Rosén I, Bruze M, Kautiainen A, Magnusson AL, Malmberg B, Aprea P, Granath F, Axmon A. Health effects of occupational exposure to acrylamide using hemoglobin adducts as biomarkers of internal dose. Scand J Work Environ Health 2001;27:219-26.
3. Urban M, Kavvadias D, Riedel K, Scherer G, Tricker AR. Urinary mercapturic acids and a hemoglobin adduct for the dosimetry of acrylamide exposure in smokers and nonsmokers. Inhal Toxicol 2006;18:831-9.
4. Tareke E, Rydberg P, Karlsson P, Eriksson S, Törnqvist M. Acrylamide: a cooking carcinogen? Chem Res Toxicol 2000;13:517-22.
5. Tareke E, Rydberg P, Karlsson P, Eriksson S, Törnqvist M. Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J Agric Food Chem 2002;50:4998-5006.
6. Stadler RH, Blank I, Varga N, Robert F, Hau J, Guy PA, Robert MC, Riediker S. Acrylamide from Maillard reaction products. Nature 2002;419:449-50.
7. Mottram DS, Wedzicha BL, Dodson AT. Acrylamide is formed in the Maillard reaction. Nature 2002;419:448-9.
8. Zyzak DV, Sanders RA, Stojanovic M, Tallmadge DH, Eberhart BL, Ewald DK, Gruber DC, Morsch TR, Strothers MA, Rizzi GP, Villagran MD. Acrylamide formation mechanism in heated foods. J Agric Food Chem 2003;51:4782-7.
9. Dybing E, Farmer PB, Andersen M, Fennell TR, Lalljie SP, Müller DJ, Olin S, Petersen BJ, Schlatter J, Scholz G, Scimeca JA, Slimani N, et al. Human exposure and internal dose assessments of acrylamide in food. Food Chem Toxicol 2005;43:365-410.
10. Fuhr U, Boettcher MI, Kinzig-Schippers M, Weyer A, Jetter A, Lazar A, Taubert D, Tomalik-Scharte D, Pournara P, Jakob V, Harlfinger S, Klaassen T, et al. Toxicokinetics of acrylamide in humans after ingestion of a defined dose in a test meal to improve risk assessment for acrylamide carcinogenicity. Cancer Epidemiol Biomarkers Prev 2006;15:266-71.
11. Sumner SC, Williams CC, Snyder RW, Krol WL, Asgharian B, Fennell TR. Acrylamide: a comparison of metabolism and hemoglobin adducts in rodents following dermal, intraperitoneal, oral, or inhalation exposure. Toxicol Sci 2003;75:260-70.
12. Miller MJ, Carter DE, Sipes IG. Pharmacokinetics of acrylamide in Fisher-344 rats. Toxicol Appl Pharmacol 1982;63:36-44.
13. 14C]acrylamide in beagle dogs and miniature pigs. Food Chem Toxicol 1987;25:871-5.
14. Doerge DR, Young JF, McDaniel LP, Twaddle NC, Churchwell MI. Toxicokinetics of acrylamide and glycidamide in B6C3F1 mice. Toxicol Appl Pharmacol 2005;202:258-67.
15. Doerge DR, Young JF, McDaniel LP, Twaddle NC, Churchwell MI. Toxicokinetics of acrylamide and glycidamide in Fischer 344 rats. Toxicol Appl Pharmacol 2005;208:199-209.
16. Hashimoto K, Aldridge WN. Biochemical studies on acrylamide, a neurotoxic agent. Biochem Pharmacol 1970;19:2591-604.
17. Calleman CJ, Bergmark E, Costa LG. Acrylamide is metabolized to glycidamide in the rat: evidence from hemoglobin adduct formation. Chem Res Toxicol 1990;3:406-12.
18. Sumner SC, Fennell TR, Moore TA, Chanas B, Gonzalez F, Ghanayem BI. Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice. Chem Res Toxicol 1999;12:1110-16.
19. Ghanayem BI, McDaniel LP, Churchwell MI, Twaddle NC, Snyder R, Fennell TR, Doerge DR. Role of CYP2E1 in the epoxidation of acrylamide to glycidamide and formation of DNA and hemoglobin adducts. Toxicol Sci 2005;88:311-18.
20. Boettcher MI, Schengen T, Kütting B, Pischetsrieder M, Angerer J. Mercapturic acids of acrylamide and glycidamide as biomarkers of the internal exposure to acrylamide in the general population. Mutat Res 2005;580:167-76.
21. Bjellaas T, Janák K, Lundanes E, Kronberg L, Becher G. Determination and quantification of urinary metabolites after dietary exposure to acrylamide. Xenobiotica 2005;35:1003-18.
22. Hashimoto K, Tanii H. Mutagenicity of acrylamide and its analogues in Salmonella typhimurium. Mutat Res 1985;158:129-33.
23. Besaratinia A, Pfeifer GP. Genotoxicity of acrylamide and glycidamide. J Natl Cancer Inst 2004;96:1023-9.
24. Twaddle NC, McDaniel LP, Gamboa da CG, Churchwell MI, Beland FA, Doerge DR. Determination of acrylamide and glycidamide serum toxicokinetics in B6C3F1 mice using LC-ES/MS/MS. Cancer Lett 2004;207:9-17.
25. Segerback D, Calleman CJ, Schroeder JL, Costa LG, Faustman EM. Formation of N-7-(2-carbamoyl-2-hydroxyethyl)guanine in DNA of the mouse and the rat following intraperitoneal administration of [14C]acrylamide. Carcinogenesis 1995;16:1161-5.
26. Paulsson B, Granath F, Grawe J, Ehrenberg L, Törnqvist M. The multiplicative model for cancer risk assessment: applicability to acrylamide. Carcinogenesis 2001;22:817-19.
27. Johnson KA, Gorzinski SJ, Bodner KM, Campbell RA, Wolf CH, Friedman MA, Mast RW. Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol 1986;85:154-68.
28. Friedman MA, Dulak LH, Stedham MA. A lifetime oncogenicity study in rats with acrylamide. Fundam Appl Toxicol 1995;27:95-105.
29. Besaratinia A, Pfeifer GP. A review of mechanisms of acrylamide carcinogenicity. Carcinogenesis 2007;28:519-28.
30. Mucci LA, Dickman PW, Steineck G, Adami HO, Augustsson K. Dietary acrylamide and cancer of the large bowel, kidney, and bladder: absence of an association in a population-based study in Sweden. Br J Cancer 2003;88:84-9.
31. Mucci LA, Lindblad P, Steineck G, Adami HO. Dietary acrylamide and risk of renal cell cancer. Int J Cancer 2004;109:774-6.
32. Mucci LA, Adami HO, Wolk A. Prospective study of dietary acrylamide and risk of colorectal cancer among women. Int J Cancer 2006;118:169-73.
33. Pelucchi C, Galeone C, Levi F, Negri E, Franceschi S, Talamini R, Bosetti C, Giacosa A, La VC. Dietary acrylamide and human cancer. Int J Cancer 2006;118:467-71.
34. Mucci LA, Sandin S, Balter K, Adami HO, Magnusson C, Weiderpass E. Acrylamide intake and breast cancer risk in Swedish women. JAMA 2005;293:1326-7.
35. Bergmark E. Hemoglobin adducts of acrylamide and acrylonitrile in laboratory workers, smokers and nonsmokers. Chem Res Toxicol 1997;10:78-84.
36. Fennell TR, Sumner SC, Snyder RW, Burgess J, Spicer R, Bridson WE, Friedman MA. Metabolism and hemoglobin adduct formation of acrylamide in humans. Toxicol Sci 2005;85:447-59.
37. Tareke E, Twaddle NC, McDaniel LP, Churchwell MI, Young JF, Doerge DR. Relationships between biomarkers of exposure and toxicokinetics in Fischer 344 rats and B6C3F1 mice administered single doses of acrylamide and glycidamide and multiple doses of acrylamide. Toxicol Appl Pharmacol 2006;217:63-75.
38. Paulsson B, Athanassiadis I, Rydberg P, Törnqvist M. Hemoglobin adducts from glycidamide: acetonization of hydrophilic groups for reproducible gas chromatography/tandem mass spectrometric analysis. Rapid Commun Mass Spectrom 2003;17:1859-65.
39. Tjønneland A, Olsen A, Boll K, Stripp C, Christensen J, Engholm G, Overvad K. Study design, exposure variables, and socioeconomic determinants of participants in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in. Denmark. Scand J Public Health 2007;35:432-41.
40. Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry - history, content, quality and use. Dan Med Bull 1997;44:535-9.
41. AR Jensen, J Overgaard, HH Storm. Validity of breast cancer in the Danish Cancer Registry. A study based on clinical records from one county in Denmark. Eur J Cancer Prev 2002;11:359-64.
42. Fischerman K, Mouridsen HT. Danish Breast Cancer Cooperative Group (DBCG). Structure and results of the organization. Acta Oncol 1988;27:593-6.
43. Bjellaas T, Olesen PT, Frandsen H, Haugen M, Stolen LH, Paulsen JE, Alexander J, Lundanes E, Becher G. Comparison of estimated dietary intake of acrylamide with hemoglobin adducts of acrylamide and glycidamide. Toxicol Sci 2007;98:110-17.
44. Prentice RL, Breslow NE. Retrospective studies and failure time models. Biometrika 1978;65:153-8.
45. Greenland S. Avoiding power loss associated with categorization and ordinal scores in dose-response and trend analysis. Epidemiology 1995;6:450-4.
46. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 1995;6:356-65.
47. Schettgen T, Rossbach B, Kutting B, Letzel S, Drexler H, Angerer J. Determination of hemoglobin adducts of acrylamide and glycidamide in smoking and non-smoking persons of the general population. Int J Hyg Environ Health 2004;207:531-9.
48. Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME. Etiology of hormone receptor-defined breast cancer: a systematic review of the literature. Cancer Epidemiol Biomarkers Prev 2004;13:1558-68.
49. Schettgen T, Weiss T, Drexler H, Angerer J. A first approach to estimate the internal exposure to acrylamide in smoking and non-smoking adults from Germany. Int J Hyg Environ Health 2003;206:9-14.
50. Hagmar L, Wirfält E, Paulsson B, Törnqvist M. Differences in hemoglobin adduct levels of acrylamide in the general population with respect to dietary intake, smoking habits and gender. Mutat Res 2005;580:157-65.
51. Granath F, Törnqvist M. Who knows whether acrylamide in food is hazardous to humans? J Natl Cancer Inst 2003;95:842-3.
52. Hagmar L, Törnqvist M. Inconclusive results from an epidemiological study on dietary acrylamide and cancer. Br. J Cancer 2003;89:774-5.
53. Wirfàlt E, Paulsson B, Törnqvist M, Axmon A, Hagmar L. Associations between estimated acrylamide intakes, and hemoglobin AA adducts in a sample from the Malmo Diet and Cancer cohort. Eur J Clin Nutr, in press.
54. Kütting B, Schettgen T, Beckmann MW, Angerer J, Drexler H. Influence of Diet on exposure to acrylamide - reflections on the validity of a questionnaire. Ann Nutr Metab 2005;49:173-7.
55. Ha M, Mabuchi K, Sigurdson AJ, Freedman DM, Linet MS, Doody MM, Hauptmann M. Smoking cigarettes before first childbirth and risk of breast cancer. Am J Epidemiol 2007;166:55-61.
56. Lafferty JS, Kamendulis LM, Kaster J, Jiang J, Klaunig JE. Subchronic acrylamide treatment induces a tissue-specific increase in DNA synthesis in the rat. Toxicol Lett 2004;154:95-103.
57. Park J, Kamendulis LM, Friedman MA, Klaunig JE. Acrylamide-induced cellular transformation. Toxicol Sci 2002;65:177-83.